Surgical Intelligent Auxiliary Navigation Device Market Report 2026

The surgical intelligent auxiliary navigation device market size has grown rapidly in recent years. It will grow from $2.23 billion in 2025 to $2.55 billion in 2026 at a compound annual growth rate (CAGR) of 14%. The growth in the historic period can be attributed to growing adoption of computer-assisted surgical tools, increasing demand for precision in complex surgeries, rising use of navigation systems in orthopedic and neurosurgical procedures, expansion of minimally invasive surgical techniques, and growing focus on reducing surgical errors and improving patient outcomes.

The surgical intelligent auxiliary navigation device market size is expected to see rapid growth in the next few years. It will grow to $4.25 billion in 2030 at a compound annual growth rate (CAGR) of 13.7%. The growth in the forecast period can be attributed to increasing integration of artificial intelligence (AI) in surgical navigation systems, rising demand for real-time imaging and guidance, growing adoption of robot-assisted surgeries, expansion of advanced healthcare infrastructure, and a rise in investment for smart surgical instrumentation. Major trends in the forecast period include technology-driven innovations in intelligent navigation algorithms, advancements in artificial intelligence (AI)-enabled intraoperative guidance, developments in augmented reality (AR) and three-dimensional (3D) visualization systems, rising research and development in precision surgical devices, and innovation in integrated data and imaging platforms.

The growing adoption of computer-assisted and precision surgeries is expected to drive the expansion of the surgical intelligent auxiliary navigation device market in the coming years. Computer-assisted and precision surgeries involve the use of advanced imaging, navigation, and digital guidance technologies to improve surgical accuracy, reduce invasiveness, and enhance patient outcomes. The uptake of computer-assisted and precision surgeries is increasing as hospitals aim to achieve better surgical results while minimizing complications, shortening recovery times, and improving the efficient use of operating room resources. Surgical intelligent auxiliary navigation devices support these procedures by offering real-time navigation, three-dimensional visualization, and data-driven guidance that help surgeons accurately position instruments and make informed decisions during operations. For example, in June 2025, according to NHS England, a UK-based government department, by 2035 this innovative approach is expected to support approximately half a million operations each year, a substantial increase from 70,000 in 2023-24, with robotic assistance projected to be used in about 90% of keyhole surgeries, including procedures for removing cancer-affected organs. As a result, the increasing adoption of computer-assisted and precision surgeries is fueling the growth of the surgical intelligent auxiliary navigation device market.

Major companies operating in the surgical intelligent auxiliary navigation device market are concentrating on the development of advanced products, such as artificial intelligence (AI) image enhancement capabilities, to enhance visualization, improve accuracy, and support better intraoperative decision-making. AI image enhancement functionality involves the use of machine learning algorithms to automatically refine, clarify, and emphasize critical anatomical structures in medical images, allowing surgeons to view greater detail and make more informed decisions during procedures. For example, in March 2023, Augmedics Inc., a US-based medical technology company focused on augmented reality solutions for surgery, introduced new features and indications for its xvision AR platform. This update incorporates AI image enhancement capabilities that improve the clarity and contrast of imaging overlays in real time, helping surgeons more accurately navigate complex anatomy. By integrating AI-enhanced visualization with augmented reality, xvision supports safer and more efficient surgical navigation and contributes to improved patient outcomes through enhanced intraoperative guidance.

In January 2023, GE Healthcare Technologies Inc., a US-based provider of medical imaging and healthcare technology, acquired IMACTIS for an undisclosed amount. Through this acquisition, GE HealthCare seeks to strengthen its interventional guidance portfolio by incorporating the IMACTIS CT-Navigation system, thereby improving procedural accuracy, workflow efficiency, and patient outcomes across minimally invasive percutaneous procedures. IMACTIS is a France-based medical technology company operating in the surgical intelligent or navigation assistance device space, with a specific focus on image-guided interventional navigation technologies.

Major companies operating in the surgical intelligent auxiliary navigation device market are Stryker Corporation, Renishaw plc, CMR Surgical Ltd., Synaptive Medical Inc., ClearPoint Neuro Inc., Augmedics Ltd., Stereotaxis Inc., Xoran Technologies LLC, Novarad Corp., Intellijoint Surgical Inc., Proprio, Fiagon GmbH, Brainomix Ltd., Surgical Theater LLC, Cascination AG, Medivis Inc., Asensus Surgical Inc., ClaroNav Inc., Centerline Biomedical Inc., Medicaroid Corporation, SpineGuard SA.

North America was the largest region in the surgical intelligent auxiliary navigation device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the surgical intelligent auxiliary navigation device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the surgical intelligent auxiliary navigation device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs have impacted the temperature-controlled packaging solutions market by increasing costs of raw materials such as plastics, polymers, aluminum, and advanced insulation components used in active and passive packaging systems. active packaging and insulated shipper segments are most affected, particularly in regions dependent on cross-border material sourcing such as north america, europe, and asia-pacific. these cost pressures can raise overall logistics expenses for healthcare and food sectors. however, tariffs are also driving material innovation, local sourcing strategies, and greater adoption of reusable and hybrid packaging solutions, strengthening long-term supply chain resilience.

Surgical intelligent auxiliary navigation devices are advanced medical tools designed to deliver real-time guidance and visualization during surgical procedures. They integrate imaging technologies, sensors, and AI algorithms to help surgeons accurately navigate anatomical structures. These devices enhance surgical precision, minimize risk, and improve patient outcomes, and are commonly applied in complex procedures such as orthopedic surgery, neurosurgery, and minimally invasive interventions.

The primary components of surgical intelligent auxiliary navigation devices are hardware, software, services, and others. Hardware includes navigation consoles, tracking sensors, imaging interfaces, and positioning systems supporting precise surgical guidance. These devices are used across minimally invasive surgery, open surgery, and other procedure types, based on optical navigation, electromagnetic navigation, robotic-assisted navigation, and related technologies, applied in orthopedic surgeries, neurosurgery, spinal procedures, ENT and maxillofacial surgery, and others, among end users including hospitals, surgical centers, ambulatory surgical centers, and specialized institutes.

The surgical intelligent auxiliary navigation device market consists of revenues earned by entities by providing services such as real-time surgical navigation support, image-guided procedure planning, intraoperative positioning and tracking assistance, artificial intelligence-based decision support, and system installation, training, and maintenance services. The market value includes the value of related goods sold by the service provider or included within the service offering. The surgical intelligent auxiliary navigation device market also includes sales of intelligent surgical navigation systems, computer-assisted surgery navigation devices, sensor-based tracking modules, navigation software integrated hardware units, and artificial intelligence-enabled surgical guidance platforms. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.